Ubs Group Ag Vbi Vaccines Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.29 - $0.64 $3,079 - $6,796
-10,620 Reduced 8.44%
115,259 $34,000
Q4 2022

Feb 08, 2023
BUY
$0.38 - $22.5 $46,562 - $2.76 Million
122,534 Added 3663.2%
125,879 $49,000
Q2 2022

Aug 10, 2022
SELL
$0.66 - $1.81 $678,980 - $1.86 Million
-1,028,758 Reduced 99.68%
3,345 $3,000
Q1 2022

May 16, 2022
BUY
$1.27 - $2.47 $410,155 - $797,703
322,957 Added 45.54%
1,032,103 $1.71 Million
Q4 2021

Feb 14, 2022
BUY
$2.21 - $3.22 $550,172 - $801,609
248,947 Added 54.1%
709,146 $1.66 Million
Q3 2021

Nov 15, 2021
BUY
$2.8 - $3.72 $1.13 Million - $1.5 Million
402,895 Added 703.08%
460,199 $1.43 Million
Q2 2021

Aug 13, 2021
SELL
$2.61 - $4.17 $1.26 Million - $2.02 Million
-483,271 Reduced 89.4%
57,304 $192,000
Q1 2021

May 12, 2021
BUY
$2.91 - $4.32 $1.57 Million - $2.34 Million
540,575 New
540,575 $1.68 Million
Q4 2020

Feb 11, 2021
SELL
$2.15 - $3.5 $2,150 - $3,500
-1,000 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$2.77 - $6.17 $207,985 - $463,274
-75,085 Reduced 98.69%
1,000 $3,000
Q2 2020

Jul 31, 2020
SELL
$0.87 - $3.13 $22,734 - $81,793
-26,132 Reduced 25.57%
76,085 $236,000
Q1 2020

May 01, 2020
SELL
$0.73 - $1.91 $99,205 - $259,565
-135,898 Reduced 57.07%
102,217 $97,000
Q4 2019

Feb 14, 2020
BUY
$0.48 - $1.38 $36,990 - $106,346
77,063 Added 47.85%
238,115 $329,000
Q3 2019

Nov 14, 2019
BUY
$0.47 - $1.05 $71,361 - $159,423
151,832 Added 1646.77%
161,052 $76,000
Q2 2019

Aug 14, 2019
BUY
$0.65 - $2.12 $5,993 - $19,546
9,220 New
9,220 $11,000
Q4 2018

Feb 14, 2019
SELL
$1.22 - $2.41 $2,421 - $4,783
-1,985 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$1.75 - $2.93 $2,814 - $4,711
1,608 Added 426.53%
1,985 $5,000
Q2 2018

Aug 14, 2018
BUY
$2.75 - $3.85 $1,036 - $1,451
377 New
377 $1,000
Q1 2018

May 15, 2018
SELL
$3.5 - $4.47 $5,957 - $7,607
-1,702 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$3.29 - $5.03 $3,141 - $4,803
955 Added 127.84%
1,702 $7,000
Q3 2017

Nov 14, 2017
SELL
$3.15 - $4.01 $22,122 - $28,162
-7,023 Reduced 90.39%
747 $3,000
Q2 2017

Aug 14, 2017
BUY
N/A
7,770
7,770 $34,000

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email